Arena Pharmaceuticals Revenue Quarterly:
2.373M for Dec. 31, 2012Arena Pharmaceuticals Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 2.373M |
| Dec. 31, 2012 | 1.936M |
| Sept. 30, 2012 | 1.485M |
| June 30, 2012 | 21.98M |
| March 31, 2012 | 2.189M |
| Dec. 31, 2011 | 2.076M |
| Sept. 30, 2011 | 3.459M |
| June 30, 2011 | 3.259M |
| March 31, 2011 | 3.925M |
| Dec. 31, 2010 | 4.012M |
| Sept. 30, 2010 | 7.629M |
| June 30, 2010 | 2.459M |
| March 31, 2010 | 2.513M |
| Dec. 31, 2009 | 2.682M |
| Sept. 30, 2009 | 2.619M |
| June 30, 2009 | 2.428M |
| March 31, 2009 | 2.658M |
| Dec. 31, 2008 | 2.698M |
| Sept. 30, 2008 | 1.857M |
| June 30, 2008 | 2.645M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
ARNA Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Vivus | 1.971M |
| Orexigen Therapeutics | 0.857M |
| Cytokinetics | 0.821M |
ARNA Revenue Quarterly Rankings
| Overall |
43rd percentile 4545 of 8002 |
| Sector |
41st percentile 398 of 684 in Healthcare |
| Industry |
62nd percentile 94 of 248 in Biotechnology |
ARNA Revenue Quarterly Range, Past 5 Years
| Minimum | 1.485M | Sep 2012 |
| Maximum | 21.98M | Jun 2012 |
| Average | 3.844M |
